OVALEAP sol inj 450 UI/0.75ml cartouche av 10 aigu

7680662550025 CH-66255 G03GA05 07.08.1.

Active substances:

OVALEAP sol inj 450 UI/0.75ml cartouche av 10 aigu
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6625502
CPT
-
Packaging group
-
Unit
1 cartouche avec 10 aiguilles d'injection
Composition
follitropinum alfa 450 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, methioninum, polysorbatum 20, alcohol benzylicus 7.5 mg, benzalkonii chloridum 0.015 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 7.7 mg.

Articles (1)

Ovaleap 450 IU/0.75 ml, solution injectable
Injektionslösung
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/02/2026
Patient information leaflet
Français
25/02/2026
Patient information leaflet
Italien
25/02/2026
Professional SmPC
Allemand
25/02/2026
Professional SmPC
Français
25/02/2026
Professional SmPC
Italien
25/02/2026

Detailed composition

Substance Quantity Type Category
follitropinum alfa
450.0 UI Substance Wirkstoff (Principe actif)
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
mannitolum
- Substance HNIDK
methioninum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
alcohol benzylicus
7.5 MG Substance HBESI
benzalkonii chloridum
0.015 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
7.7 MG Substance HBESI

Reimbursement information

Public price
CHF 166.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2018

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
66255
Drug name
Ovaleap, solution injectable
Galenic form
LSINJ
ATC Code
G03GA05
Authorization status
Z
Dispensation category
A
First authorization
28/08/2018
Authorization expiration date
31/12/9999
IT number
07.08.1.
Domain
Human medicine
Field of application
Stimulierung der Follikelreifung bei anovulatorischen Zuständen, bei ärztlich assistierten Reproduktionsprogrammen und bei Frauen mit schwerem LH- und FSH-Mangel; Stimulierung der Spermatogenese

Packaging details

Description (FR)
OVALEAP sol inj 450 UI/0.75ml cartouche av 10 aigu
Description (DE)
OVALEAP Inj Lös 450 IE/0.75ml Patrone m 10 Nadeln
Market launch
28/08/2018
Narcotic (BTM)
No

Other packaging sizes

OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu
None LEER
View
OVALEAP sol inj 900 UI/1.5ml cartouche av 20 aigu
None LEER
View
Buy us a coffee Explore the data